Our Pipeline

Program

GI restricted TGF-beta 1 inhibitor

Therapeutic Area

Discovery

Development

Hit to lead

Optimization

Preclinic

Phase 1

Colon Cancer
Crohn´s Disease
Lung-restricted TGF-β inhibitor
Idiopathic Pulmonary Fibrosis